Where does Cognito Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cognito Therapeutics, Inc. ranks #16,691 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cognito Therapeutics, Inc. hold?

Cognito Therapeutics, Inc. holds 17 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Cognito Therapeutics, Inc.'s Innovation Score?

Cognito Therapeutics, Inc. has an Innovation Score of 33.1 out of 100 (43rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cognito Therapeutics, Inc. focus on?

Cognito Therapeutics, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 10 patents, ranking #1,884 of 6,058 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Cognito Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Cognito Therapeutics, Inc.'s recent grant velocity is -22% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Cognito Therapeutics, Inc.'s patents?

Cognito Therapeutics, Inc.'s patents average 14.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cognito Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cognito Therapeutics, Inc.

USPTO PatentsView assignee record - 17 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cognito ranks #16,691 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 11 technology areas.

#16,691
of 49,997 US assignees by volume: 43rd percentile
by Innovation Score (33.1/100): 14.8
avg claims per patent: -22%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16691 · US Corporation #16,691 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 17 grants
MID-PACK #16,691/49,997
PHOTO-FINISH CG Technology…
CPC-FOCUS A61P · 11 areas
INNOV-THIN 33.1/100
CLAIMS-RICH 14.8 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -22% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: CG Technology Development, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cognito’s 33.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (30%) Velocity 2.5 pts (8%) Breadth 11.7 pts (35%) Claim depth 8.9 pts (27%)

Qualcomm Incorporated · highest

85
Cognito Therapeutics · this assignee

33
Karyopharm Therapeut… · near

33
Synaptics Display… · near

33
Tecmen · near

33
Umbra · near

33
3D Lighting… · lowest

7

What this shows Cognito's Innovation Score is 33.1/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cognito?

Each dot is one of Cognito’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cognito’s own 14.8 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cognito vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cognito's grants concentrate

Cognito Therapeutics, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 58.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2015. By volume, Cognito sits between CG Technology Development, LLC and Conventus Orthopaedics, Inc..

Cognito's three-year grant acceleration

Cognito Therapeutics, Inc. shows 3 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

CG Technology Dev…

17
Chengdu Qianniuca…

17
Chongqing Jinkang…

17
Chugoku Marine Pa…

17
Colop Stempelerze…

17
Compugroup Medica…

17
Consumer Lighting…

17
Conventus Orthopa…

17
Cognito Therapeut… ◀

17

What this shows Cognito holds 17 patents at rank #16,673, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cognito

By rank, the assignees closest to #16,673 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Cognito's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cognito, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Cognito ranks #1,884 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (33 here).

Synaptics Display Devices GK 33 Tecmen Electronics Co., Ltd 33 Karyopharm Therapeutics Inc. 33 Umbra LLC 33

Cognito's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cognito Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.9%
2016	2	11.8%
2017	2	11.8%
2019	4	23.5%
2020	3	17.6%
2021	1	5.9%
2022	1	5.9%
2023	1	5.9%
2024	1	5.9%
2025partial year	1	5.9%

Which technologies does Cognito Therapeutics, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 10

H05B - Electric HEATING; Electric Light Sources NOT Otherwise Provided FOR; Circuit Arrangements FOR Electric Light Sources, IN General 7

A61B - DIAGNOSIS; SURGERY; Identification 7

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 7

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 7

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 7

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 7

C07D - Heterocyclic Compounds 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C07C - Acyclic OR Carbocyclic Compounds 6

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cognito Therapeutics, Inc.'s patent record in context - here's where to go next.

Cognito Therapeutics, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 58.8% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #16,691 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cognito Therapeutics, Inc. against CG Technology Development, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.